Home LiteratureArticle Details
PMID: 12801742 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Abeta to physiologically relevant proteolytic degradation.

Lancet (London, England) ·Vol. 361 ·No. 9373 ·2003-06-07 ·Pages 1957-8

Tsubuki S, Takaki Y, Saido TC

Abstract

The Dutch, Flemish, Italian, and Arctic mutations in the amyloid precursor protein (APP) gene encode changes within the sequence of the amyloid beta peptide (Abeta) and cause presenile cerebral amyloid angiopathy, cerebral parenchymal amyloidosis, or both. These disorders are caused by accumulation of Abeta, with no evidence of increased Abeta production. Our results showed that these mutations in Abeta make it resistant to proteolytic degradation by neprilysin, the peptidase with the most important role in catabolism of Abeta in the brain. These mutations in Abeta could thus be pathogenic not only by facilitating fibrillogenesis but also by extending the half-life of Abeta in the brain.

MeSH Terms
Amyloid beta-Peptides/genetics,metabolism Amyloid beta-Protein Precursor/genetics,metabolism Mutation Neprilysin/pharmacology Peptide Fragments/genetics,metabolism Trypsin/pharmacology
Chemicals
Amyloid beta-Peptides Amyloid beta-Protein Precursor Peptide Fragments Trypsin Neprilysin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Tsubuki Satoshi
Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako-shi, 351-0198, Saitama, Japan.
Takaki Yoshie
Saido Takaomi C
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
2003-06-07
Pages
1957-8
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]